Pharmaceuticals

2026 is the year of obesity pills from Novo Nordisk, Eli Lilly

Read more

First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.

Read more

Nine pharma companies ink deals with Trump to lower drug prices

Read more

How donors, access and polls led Trump to reclassify marijuana

Read more

Novo Nordisk faces ‘must-win’ battle over U.S. Wegovy, Ozempic in 2026

Read more

Eli Lilly to build $6 billion Alabama manufacturing plant

Read more

RFK Jr.’s vaccine panel defers vote on hepatitis B shot for babies

Read more

Eli Lilly cuts cash prices of Zepbound weight loss drug vials

Read more

Novo Nordisk shares fall after Alzheimer’s drug trial fails to hit target

Read more

Eli Lilly hits $1 trillion market value, first for health care company

Read more